Zymergi LogoCart

483 Document: Guangdong CR Shunfeng Pharmaceutical Co., Ltd., Jul 14, 2017

FDANews 483 Guangdong CR Shunfeng Pharmaceutical Co., Ltd. Jul 14 2017 top
Tajah L. Blackburn FDA Investigator Daveta L. Bailey FDA Investigator

On Jul 14, 2017, the FDA inspected Guangdong CR Shunfeng Pharmaceutical Co., Ltd.'s Foshan City site. Explore the inspectional observations.